A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT06392477 · RECRUITING
Trial details
- NCT number
- NCT06392477
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-08
- Primary completion
- 2028-01-21
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.